- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Natco Pharma Ltd.
Headquarters: Hyderabad, India
Website: http://www.natcopharma.co.in...
Year Founded: 1981
Status: Archived
Industry Sector: HealthTechnology
CEO: Rajeev Nannapaneni
Number Of Employees: 4,800
Enterprise Value: $1,879,151,892
PE Ratio: 7.91
Exchange/Ticker 1: NSE:NATCOPHARM
Exchange/Ticker 2: BSE:524816
Latest Market Cap: $1,724,875,053
BioCentury | Mar 3, 2018
Finance
Rocky road
Buyside views on what Celgene can do to bolster sentiment after ozanimod setback
BioCentury | Jan 27, 2018
Strategy
Jump-starting growth
Analyzing Celgene’s growth prospects after Juno, Impact deals
BioCentury | Oct 28, 2017
Product Development
Chinks in the armor
What’s next for Celgene in light of mongersen failure, Otezla underperformance
BioCentury | Jan 11, 2016
Finance
Sowing season
Buysiders eyeing big cap clinical milestones in 2016 to seed next growth spurt
BioCentury | Aug 17, 2015
Strategy
Shifting MS spending
How the multiple sclerosis market slowdown will affect new entrants
Items per page:
1 - 10 of 49